Influence of opioid agonists on cardiac human ether-a-go-go-related gene K+ currents

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 688-694

  Katchman, Alexander N ^a,b   McGroary, Kelly A ^b,c   Kilborn, Michael J ^d   Kornick, Craig A ^a,e   Manfredi, Paolo L ^a   Woosley, Raymond L ^c   Ebert, Steven N ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE; FENTANYL CITRATE; LEVACETYLMETHADOL; METHADONE; MORPHINE; OPIATE AGONIST; PETHIDINE; POTASSIUM CHANNEL;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; HEART FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; IC 50; LONG QT SYNDROME; POTASSIUM CURRENT; PRIORITY JOURNAL; STEADY STATE;

CATION TRANSPORT PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; METHADONE; METHADYL ACETATE; NARCOTICS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0036828152     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.038240     Document Type: Article

References (42)

1. Ahonen J, Olkkola KT, Hynynen M, Seppala T, Ikavalko H, Remmerie B, and Salmenpera M (2000) Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth 85:533-540.
2. Antzelevitch C, Sun ZQ, Zhang ZQ, and Yan GX (1996) Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol 28:1836-1848.
3. Auriacombe M, Franques P, and Tignol J (2001) Deaths attributable to methadone vs buprenorphine in France. J Am Med Assoc 285:45.
4. Ayonrinde OT and Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173:536-540.
5. Band CJ, Band PR, Deschamps M, Besner JG, and Coldman AJ (1994) Human pharmacokinetic study of immediate-release (codeine phosphate) and sustained-release (codeine Contin) codeine. J Clin Pharmacol 34:938-943.
6. Bowler GM, Galloway DW, Meiklejohn BH, and Macintyre CC (1986) Sharp fall in blood pressure after injections of heparin containing chlorbutol. Lancet 1:848-849.
7. Bruera E and Sweeney C (2002) Methadone use in cancer patients with pain: A review. J Palliat Med 5:127-138.
8. Cavero I, Mestre M, Guillon JM, and Crumb W (2000) Drugs that prolong QT interval as an unwanted effect: Assessing their likelihood of inducing hazardous cardiac dysrhythmias. Exp Opin Pharmacother 1:947-973.
9. De Ponti F, Poluzzi E, and Montanaro N (2001) Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: A call for consensus. Eur J Clin Pharmacol 57:185-209.
10. de Vos JW, Geerlings PJ, van den BW, Ufkes JG and van Wilgenburg H (1995) Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol 48:361-366.
11. Deamer RL, Wilson DR, Clark DS, and Prichard JG (2001) Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis 20:7-14.
12. Ekins S, Crumb WJ, Sarazan RD, Wikel JH, and Wrighton SA (2002) Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. J Pharmacol Exp Ther 301:427-434.
13. Faber T, Zehender M, and Just H (1994) Drug-induced torsade de pointes. Drug Safety 11:463-476.
14. Faura CC, Moore RA, Horga JF, Hand CW, and McQuay HJ (1996) Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain. J Pain Symptom Manage 11:95-102.
15. Ferreira S, Crumb WJ Jr, Carlton CG, and Clarkson CW (2001) Effects of cocaine and its major metabolites on the HERG-encoded potassium channel. J Pharmacol Exp Ther 299:220-226.
16. Ficker E, Jarolimek W, Kiehn J, Baumann A, and Brown AM (1998) Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 82:386-395.
17. Goodman J and Peter C (1995) Proarrhythmia: Primum non nocere, in Cardiac Arrhythmias (Their Mechanisms, Diagnosis and Management) (Mandel W ed) pp 173-191, Lippincott, Williams & Wilkins, Philadelphia.
18. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
19. Henderson GL, Wilson BK, and Lau DH (1977) Plasma 1-alpha-Acetylmethadol (LAAM) after acute and chronic administration. Clin Pharmacol Ther 21:16-25.
20. Hermsmeyer K and Aprigliano O (1976) Effects of chlorobutanol and bradykinin on myocardial excitation. Am J Physiol 230:306-310.
21. Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, and Foley KM (1987) Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 41:392-401.
22. January CT, Gong Q, and Zhou Z (2000) Long QT syndrome: Cellular basis and arrhythmia mechanism in LQT2. J Cardiovasc Electrophysiol 11:1413-1418.
23. Joseph H, Stancliff S, and Langrod J (2000) Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mt Sinai J Med 67:347-364.
24. Lees-Miller JP, Duan Y, Teng GQ, and Duff HJ (2000) Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: Involvement of S6 sites. Mol Pharmacol 57:367-374.
25. Liu X-K, Katchman A, Drici M-D, Ebert S, Ducic I, Morad M, and Woosley R (1998a) Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 285:672-679.
26. Kr, in rabbit ventricular myocytes. J Pharmacol Exp Ther 287:877-883.
27. Manfredi PL, Borsook D, Chandler SW, and Payne R (1997) Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: Clinical observations. Pain 70:99-101.
28. Mitcheson JS, Chen J, Lin M, Culberson C, and Sanguinetti MC (2000) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97:12329-12333.
29. Mohammad S, Zhou Z, Gong Q, and January CT (1997) Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol 273:H2534-H2538.
30. Prendergast ML, Grella C, Perry SM, and Anglin MD (1995) Levo-α-acetylmethadol (LAAM): Clinical, research and policy issues of a new pharmacotherapy for opioid addiction. J Psychoactive Drugs 27:239-247.
31. Ripamonti C and Dickerson ED (2001) Strategies for the treatment of cancer pain in the new millennium. Drugs 61:955-977.
32. Salata JJ, Jurkiewicz NK, Jow B, Folander K, Guinosso PJ Jr, Raynor B, Swanson R, and Fermini B (1996) IK of rabbit ventricle is composed of two currents: Evidence for IKs. Am J Physiol 271:H2477-H2489.
33. Sanguinetti MC and Jurkiewicz NK (1990) Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215.
34. Santiago-Palma J, Ebojainova N, Kornick C, Fischberg DJ, Primavera LH, Payne R, and Manfredi P (2001) Intravenous methadone in the management of chronic cancer pain: Safe and effective starting doses when substituting methadone for fentanyl. Cancer 92:1919-1925.
35. Sprigge JS, East DS, Fox GS, Ogilvie RI, Otton PE, and Bevan DR (1982) Meperidine infusion for postoperative analgesia in grossly obese patients. Can Anaesth Soc J 29:142-147.
36. Tamargo J (2000) Drug-induced torsade de pointes: From molecular biology to bedside. Jpn J Pharmacol 83:1-19.
37. Tseng GN (2001) I(Kr): The hERG channel. J Mol Cell Cardiol 33:835-849.
38. USP DI (1999) Volume I: Drug Information for the Health Care Professional. Micromedix, Inc., Englewood, CO.
39. Viskin S (1999) Long QT syndromes and torsade de pointes. Lancet 354:1625-1633.
40. Wang W, Ebert S, Liu X-K, Chen Y, Drici M-D, and Woosley R (1998) "Conventional" antihistamines slow cardiac repolarization in isolated perfused (Langendorff) feline hearts. J Cardiovasc Pharmacol 32:123-128.
41. Yang T, Snyders D, and Roden DM (2001) Drug block of I(kr): Model systems and relevance to human arrhythmias. J Cardiovasc Pharmacol 38:737-744.
42. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, and January CT (1998) Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74:230-241.